PCSA Return on Tangible Equity | Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc. (PCSA) Return on Tangible Equity

2026-06-30: Return Tang Equity 172.67%.
2026-03-31: Return Tang Equity 286.46%.
2025-12-31: Return Tang Equity 718.44%.
2025-09-30: Return Tang Equity 792.66%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	172.67%
2026-03-31	286.46%
2025-12-31	718.44%
2025-09-30	792.66%
2025-06-30	948.54%
2025-03-31	303.61%
2024-12-31	205.41%
2024-09-30	307.82%
2024-06-30	709.18%
2024-03-31	-692.89%
2023-12-31	449.15%
2023-09-30	7306.61%
2023-06-30	-1514.82%
2023-03-31	-1054.14%
2022-12-31	-500899.16%
2022-09-30	-180.01%
2022-06-30	-117.26%
2022-03-31	-81.65%
2021-12-31	-65.57%
2021-09-30	-94.85%
2021-06-30	-86.87%
2021-03-31	-68.93%
2020-12-31	-102.28%
2020-09-30	154.98%
2020-06-30	122.40%
2020-03-31	157.56%
2019-12-31	206.02%
2019-09-30	272.73%
2019-06-30	206.88%
2019-03-31	306.59%
2018-12-31	511.02%
2018-09-30	2900.17%
2018-06-30	-741.76%
2018-03-31	72.80%
2017-12-31	-497.45%
2017-09-30	8257.34%
2017-06-30	90.37%
2017-03-31	82.71%
2016-12-31	84.56%
2016-09-30	27.02%
2016-06-30	38.49%
2016-03-31	134.24%
2015-12-31	3913.68%
2015-09-30	280.00%
2015-06-30	380.65%
2015-03-31	-545.26%
2014-12-31	-374.71%
2014-09-30	3249.52%
2014-06-30	-597.32%
2014-03-31	-349.32%
2013-12-31	-183.66%
2013-09-30	-128.09%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	547.08%
2024-12-31	186.31%
2023-12-31	362.56%
2022-12-31	4680.73%
2021-12-31	-65.57%
2020-12-31	-102.28%
2019-12-31	206.02%
2018-12-31	511.02%
2017-12-31	-497.45%
2016-12-31	84.56%
2015-12-31	3913.69%
2014-12-31	-374.71%
2013-12-31	-183.66%
2012-12-31	-95.25%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
AMARIN CORP PLC\UK (AMRN)		$0.005B	-247.24
Xenetic Biosciences, Inc. (XBIO)	United States	$0.006B
ProPhase Labs, Inc. (PRPH)	United States	$0.006B	-0.06
Dermata Therapeutics, Inc. (DRMA)	United States	$0.005B	-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)	United States	$0.005B
Cadrenal Therapeutics, Inc. (CVKD)	United States	$0.004B	-0.90
Pulmatrix, Inc. (PULM)	United States	$0.006B
Lakewood-Amedex Biotherapeutics Inc. (LABT)	United States	$0.004B
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)	United States	$0.004B	-0.59